| 1 |
33397458 | Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer. | 2021 Jan 4 |
6 |
| 2 |
33435590 | Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study. | 2021 Jan 8 |
1 |
| 3 |
34307173 | Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review. | 2021 |
5 |
| 4 |
29584739 | Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients? | 2018 |
2 |
| 5 |
27677313 | Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer. | 2016 Sep 27 |
3 |
| 6 |
25354091 | Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells. | 2015 Jan |
1 |
| 7 |
25866324 | Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates. | 2015 Jun |
3 |
| 8 |
25892674 | HE4 in the differential diagnosis of ovarian masses. | 2015 Jun 15 |
1 |
| 9 |
24748235 | Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? | 2014 Jul |
2 |
| 10 |
24975515 | HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation. | 2014 Jun 30 |
2 |
| 11 |
25018782 | Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer. | 2014 |
1 |
| 12 |
23178313 | Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study. | 2013 Feb |
1 |
| 13 |
23095772 | The prognostic and predictive value of combined HE4 and CA-125 in ovarian cancer patients. | 2012 Nov |
1 |
| 14 |
21683503 | Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer. | 2011 Oct |
1 |